Related Experiment Videos
Nephrotoxicity in combined cephalothin and gentamicin therapy
Acta Medica Scandinavica
|January 1, 1977
Summary
Cephalothin and gentamicin combination therapy can cause kidney damage, especially in patients with pre-existing renal issues. Short-term use in patients with normal kidney function poses minimal risk for nephrotoxicity.
Area of Science:
- Nephrology
- Pharmacology
- Infectious Diseases
Background:
- The combination of cephalothin and gentamicin is frequently used for life-threatening infections.
- Assessing the nephrotoxicity risk associated with this antibiotic combination is crucial.
Observation:
- Thirty-two treatment series of cephalothin and gentamicin were administered to 26 patients.
- Renal impairment, indicated by increased serum creatinine, was observed in 6 treatment series.
- Transient hypokalemia occurred in 11 out of 28 treatment series.
Findings:
- Elevated pretreatment serum creatinine, high serum gentamicin levels, and possibly high serum cephalothin levels were associated with renal damage.
- Nephrotoxicity was reversible in 2 patients; others did not survive to show improvement.
- Short-term treatment in patients with normal baseline renal function presented a low risk of nephrotoxicity.
Implications:
- Despite potential nephrotoxicity, the cephalothin-gentamicin combination remains a preferred treatment for severe infections.
- Careful patient selection and monitoring of renal function and drug levels are essential.
- Further research may explore optimizing dosing strategies to mitigate renal risks.